Lab Tested Peptides in Canada: How HPLC and Mass Spec Verify a Lot
When a lab orders dozens of vials from one lot, the whole order rests on two analytical results. One says the material is the peptide it claims to be; the other says how much of it is that peptide rather than a near relative. For lab tested peptides in Canada, those two results come from different instruments: mass spectrometry for identity, and reversed-phase HPLC for purity. Neither can stand in for the other. This guide explains what each technique measures, which settings change the answer, and how QC staff can read both before releasing a multi-vial shipment to the bench.
Two questions every lot has to answer
It helps to state the questions plainly, because a surprising number of analytical reports answer only one:
- Identity: is the main component the intended sequence, with the intended modifications?
- Purity: what share of the peptide material in the vial is that main component?
A third question, how much of the powder is peptide at all, sits outside both techniques and is covered further down. Keeping the three apart is the key to reading any certificate.
How reversed-phase HPLC puts a number on purity
In reversed-phase HPLC, a dissolved sample is pumped through a column filled with a water-repelling stationary phase, most commonly silica carrying C18 chains. The mobile phase starts mostly aqueous and becomes steadily richer in an organic solvent, typically acetonitrile, with a little trifluoroacetic acid in both solvents to sharpen peaks. More hydrophobic species hold on longer and leave the column later.
A UV detector watches the outflow and records a trace of absorbance over time. The intended peptide gives the largest peak. Related substances made during synthesis show up as smaller peaks around it:
- Deletion sequences, where one amino acid failed to couple.
- Truncated chains that stopped growing early.
- Species still carrying a protecting group that was not fully removed.
- Oxidised or deamidated forms that arise during synthesis or storage.
Purity is the area of the main peak as a percentage of the combined area of all integrated peaks. It is a ratio among the things the detector can see, which is an important limit on what it can tell you.
Settings that move the purity figure
Two laboratories can analyse the same vial and report different numbers without either being wrong. The main reasons:
| Setting | What changes | What to look for on a report |
|---|---|---|
| Detection wavelength | Around 214 nm the peptide bond itself absorbs; around 280 nm only aromatic residues do, so impurities lacking them fade from view | A stated wavelength, ideally in the 210 to 220 nm region |
| Gradient slope | A fast gradient squeezes peaks together and can bury a neighbouring impurity in the main peak | Gradient and run time listed alongside the result |
| Peak shape | A shoulder, tail or flattened top can mean two species leaving the column almost together | A chromatogram image, not just a percentage |
This is why the trace matters more than the headline figure. Looking at it, you can tell whether the missing couple of percent is one sizeable impurity or a spread of tiny ones, and whether the main peak looks clean. Our guide to reading an HPLC chromatogram goes through examples.
Mass spectrometry and what the mass tells you
HPLC shows a sample is uniform; it cannot say what the uniform thing is. A mass spectrometer ionises the molecules and sorts them by mass-to-charge ratio, giving an observed mass that can be set beside the value calculated from the sequence.
Two ionisation approaches cover most peptide work:
- Electrospray (ESI) produces ions carrying several charges and couples directly to liquid chromatography, so one LC-MS run can both separate and identify.
- MALDI-TOF mixes the sample into a matrix, fires a laser to ionise it, and times the ions’ flight down a tube. It mostly gives singly charged ions and copes better with salty samples.
When observed and calculated masses agree within the instrument’s accuracy, identity is confirmed. When they do not, the size of the gap is itself a clue:
- A shortfall equal to one residue’s mass points to a deletion sequence.
- About +16 Da suggests oxidation, often at methionine.
- About +1 Da can signal deamidation of asparagine or glutamine; see our note on the 0.98 dalton deamidation shift.
When one dalton matters: PT-141 and Melanotan II
A good test of whether a mass result means anything is a pair of compounds that are almost the same. PT-141 and Melanotan II share the same cyclic core. The difference is at the C-terminus: Melanotan II ends in an amide, PT-141 in a free acid. That swap changes the mass by roughly one dalton.
On HPLC the two can behave very similarly, so a purity figure alone will not tell them apart. Only a mass result reported beside the correct calculated value does. For QC, this is a useful habit: when a catalogue contains close structural neighbours, check that the calculated mass on the certificate belongs to the compound you ordered, not its sibling. Our structural comparison of the melanocortin peptides sets out the differences.
The missing third number: net peptide content
Neither technique measures how much peptide is actually in the vial. Freeze-dried peptide is delivered in salt form, frequently with trifluoroacetate as the counter-ion, and it picks up moisture. A vial filled to 10 mg therefore holds peptide, counter-ion and some water. HPLC purity divides peptide species among themselves and ignores that mass balance entirely.
Net peptide content is measured separately, usually by amino acid analysis or by nitrogen determination, and it commonly lands somewhere between about 70 and 90 percent of the solid. Karl Fischer titration gives the water content. If neither figure is available, a concentration worked out from the vial weight has an error nobody has sized. Our article on amino acid analysis explains the method.
What lab tested peptides in Canada should mean for a bulk order
For a buyer receiving many vials at once, “tested” is only useful if the results can be tied to the vials in hand and read with the details above. A practical release checklist:
- Match each vial group to its certificate and note the pairing in the inventory log.
- Confirm the calculated mass on the certificate is correct for the compound ordered, and that the observed mass agrees with it.
- Check that the HPLC result states the wavelength and that a chromatogram is attached.
- Look for net peptide content, and base stock concentrations on it where it is given.
- Keep a copy of each certificate with the lot record so reorders can be compared against the original trace.
Bulk Peptides products are third-party tested for HPLC purity. Certificates are published for some products on our certificates of analysis page, and vials are matched to their certificate by cap and crimp colour. For a step-by-step reading of a full report, see how to read a certificate of analysis.
All compounds mentioned are supplied only for in-vitro laboratory research and analytical work. They are not intended for human or veterinary use.
